{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-22-002518","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2022-11-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.292463+00:00","generated_at":"2026-06-21T12:37:23.520237+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Lexaria Bioscience replaces auditor; Davidson declines re-election, MaloneBailey appointed","bullets":["Davidson & Company LLP will not stand for re-election after completing FY2022 audit.","No disagreements or reportable events with Davidson during FY2022 and FY2021.","Audit Committee selected MaloneBailey LLP as new independent auditor effective Nov 25, 2022.","No prior consultations with MaloneBailey regarding accounting principles or audit opinions."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-22-002518","json":"https://secwatch.observer/filing/0001640334-22-002518.json","markdown":"https://secwatch.observer/filing/0001640334-22-002518.md","text":"https://secwatch.observer/filing/0001640334-22-002518.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033422002518/0001640334-22-002518-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033422002518/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T12:37:23.520237+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2904abc89bcdc1d5066bb1a05c4b07bda4ea2b0b","claim":"Lexaria Bioscience Corp. engaged MaloneBailey LLP as its auditor.","evidence_excerpt":"the Board of Directors accepted this recommendation and approved the appointment of MaloneBailey effective as of November 25, 2022.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1348362/000164033422002518/0001640334-22-002518-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"MaloneBailey LLP"}],"fact_type":"auditor_change"},{"claim_id":"5488b5afa92c17bae925e2127b90ceb0b038cbf9","claim":"Davidson & Company LLP resigned as auditor of Lexaria Bioscience Corp..","evidence_excerpt":"Davidson & Company LLP (“Davidson & Co.”), advised Lexaria Bioscience Corp. (the “Registrant”) that it would not stand for re-election as the Registrant’s Certifying Accountant after completing its audit of the Registrant’s year end financial statements.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1348362/000164033422002518/0001640334-22-002518-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"resignation"},{"label":"Auditor","value":"Davidson & Company LLP"},{"label":"Successor","value":"MaloneBailey LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}